載入...
Ex vivo fucosylation of third-party human regulatory T cells enhances anti–graft-versus-host disease potency in vivo
Adoptive therapy with regulatory T cells (Tregs) to prevent graft-versus-host disease (GVHD) would benefit from a strategy to improve homing to the sites of inflammation. We hypothesized that adding fucose to human Tregs, forming the Sialyl Lewis X moiety on P-selectin glycoprotein ligand-1, would i...
Na minha lista:
發表在: | Blood |
---|---|
Main Authors: | , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
American Society of Hematology
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342362/ https://ncbi.nlm.nih.gov/pubmed/25428215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-10-603449 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|